Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Buy
27,160
+2,994
+12% +$213K 0.07% 156
2025
Q4
$1.68M Sell
24,166
-2,079
-8% -$146K 0.24% 69
2025
Q3
$1.82M Sell
26,245
-3,411
-12% -$244K 0.26% 70
2025
Q2
$2.22M Sell
29,656
-26,721
-47% -$2.07M 0.31% 63
2025
Q1
$4.57M Hold
56,377
0.82% 32
2024
Q4
$5.02M Sell
56,377
-3,293
-6% -$332K 0.87% 34
2024
Q3
$6.88M Buy
59,670
+26,472
+80% +$2.77M 1.19% 20
2024
Q2
$3.16M Sell
33,198
-910
-3% -$82.1K 0.58% 41
2024
Q1
$2.82M Hold
34,108
0.5% 46
2023
Q4
$3M Buy
+34,108
New +$2.79M 0.62% 38

Other funds holding EXPO

Mirova's EXPO Position: Q1 2026 in Review

Mirova increased its Exponent (EXPO) stake by 12% in Q1 2026, buying an estimated $213K and bringing the position to 27,160 shares worth $1.77M. The position accounts for 0.07% of the portfolio, ranked #156.

Mirova first reported a position in EXPO in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.88M in Q3 2024. 361 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Mirova held 27,160 shares of Exponent worth $1.77M as of Q1 2026.
  • Mirova bought 2,994 Exponent shares in Q1 2026, an estimated $213K.
  • Exponent made up 0.07% of Mirova's portfolio in Q1 2026, its #156 holding.
  • Mirova first reported a position in Exponent in Q4 2023 and has held it in 10 quarters since.
  • Mirova's Exponent position peaked at $6.88M in Q3 2024.
  • 361 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Mirova's 13F filing for Q1 2026, filed 14 May 2026.